Report summary

Notifier

Name

Quantass ApS

Reason for notification

Closely associated

Yes

Person discharging managerial responsibilities

Jeppe Øvlesen

Position

CEO/Verkställande direktör

Initial notification

Yes

Amendment

Details of amendment

Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor

Name

SynAct Pharma AB

LEI

549300RRYIEFEQ72N546

Details of transaction

Type of financial instrument	Name	ISIN code	Nature of transaction	Linked to a share option programme	Volume	Unit	Price per unit	Currency code	Transaction date	Place of the transaction
BTU	SynAct Pharma BTU	SE0013409653	Subscription		7,460	Quantity	24.80	SEK	27/11/2019	Outside a trading venue

Aggregation

Name	ISIN code	Nature of transaction	Transaction date	Place of the transaction	Volume	Weighted average price
SynAct Pharma BTU	SE0013409653	Subscription	27/11/2019	Outside a trading venue	7,460 (Quantity)	24.80 SEK
				Total:	7,460

<< Back